Quest Diagnostics (DGX) Non-Current Debt (2009 - 2026)

Quest Diagnostics has disclosed Non-Current Debt across 18 years of filings, most recently posting $5.2 billion for Q1 2026.

• Non-Current Debt for Q1 2026 came in at $5.2 billion, down 12.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 billion (down 12.0% YoY), and the FY2025 annual result was $5.2 billion, down 7.98% from the prior year.
• Non-Current Debt came in at $5.2 billion for Q1 2026 at Quest Diagnostics, roughly flat from $5.2 billion in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $5.9 billion in Q1 2025 to a low of $3.8 billion in Q2 2023.
• The 5-year median for Non-Current Debt is $4.0 billion (2022), against an average of $4.6 billion.
• Across the five-year window, Non-Current Debt soared 54.0% in 2025 and decreased 12.0% in 2026, its largest moves.
• Quest Diagnostics' Non-Current Debt stood at $4.0 billion in 2022, then climbed by 10.86% to $4.4 billion in 2023, then gained by 27.32% to $5.6 billion in 2024, then slipped by 7.98% to $5.2 billion in 2025, then dropped by 0.23% to $5.2 billion in 2026.
• The last three Non-Current Debt figures came in at $5.2 billion (Q1 2026), $5.2 billion (Q4 2025), and $5.2 billion (Q3 2025), per Business Quant data.